Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy (Adv. Mater. 37/2021). Issue 37 (14th September 2021)

• Record Type: Journal Article
• Authors: Liu, Chuang; Sun, Shan; Feng, Qiang; Wu, Gongwei; Wu, Yiting; Kong, Na; Yu, Zhangsen; Yao, Junlie; Zhang, Xingcai; Chen, Wei; Tang, Zhongmin; Xiao, Yufen; Huang, Xiangang; Lv, Aman; Yao, Chenyang; Cheng, Haibo; Wu, Aiguo; Xie, Tian; Tao, Wei
• Is Part Of: Advanced materials. Volume 33:Issue 37(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-09-14
• Subjects: 2D materials -- arsenene nanodots -- ß‐elemene -- combination cancer therapy -- selective killing effects; Materials -- Periodicals; Chemical vapor deposition -- Periodicals; 620.11
• DOI: 10.1002/adma.202170292
• Languages: English
• ISSNs: 0935-9648

Abstract

Abstract : Arsenical Drugs In article number 2102054, Aiguo Wu, Tian Xie, Wei Tao, and co‐workers reveal PEGylated arsenene nanodots (AsNDs@PEG) with high monoelemental arsenic purity and negligible systemic toxicity as a new‐concept arsenical drug. This AsNDs@PEG, when applied in a low‐dose combination strategy with β‐elemene, a plant‐derived anticancer drug, achieves synergistic therapeutic outcomes.